more general categories |
information about this item |
|
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
|
|
|
|
|
|
|
|
|
Growth Hormone-Secreting Pituitary Adenoma [MESH:D049912] (383) |
|
|
Prolactinoma [MESH:D015175] (312) |
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
|
|
|
Leydig Cell Tumor [MESH:D007984] (267) |
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
Growth Hormone-Secreting Pituitary Adenoma [MESH:D049912] (383) |
|
|
Prolactinoma [MESH:D015175] (312) |
|
|
|
|
|
Leydig Cell Tumor [MESH:D007984] (267) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
|
|
|
Lung Neoplasms [MESH:D008175] (6015) |
|
|
|
|
|
|
|
|
|
|
|
Leydig Cell Tumor [MESH:D007984] (267) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
 |
C05. Musculoskeletal Diseases |
 |
 |
|
C05. Musculoskeletal Diseases |
|
|
|
|
|
|
|
|
|
|
|
Fibrous Dysplasia of Bone [MESH:D005357] (737) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
 |
C08. Respiratory Tract Diseases |
 |
 |
|
C08. Respiratory Tract Diseases |
|
|
|
|
|
Lung Neoplasms [MESH:D008175] (6012) |
|
|
Apnea [MESH:D001049] (748) |
|
|
Lung Neoplasms [MESH:D008175] (6013) |
|
 |
C10. Nervous System Diseases |
 |
 |
|
C10. Nervous System Diseases |
|
|
Not Fully Specified [NFS] (4027) |
|
|
|
|
|
|
|
|
Brain Injuries [MESH:D001930] (3429) |
|
|
|
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
|
|
|
|
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
|
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Status Epilepticus [MESH:D013226] (4014) |
|
|
|
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
Hypopituitarism [MESH:D007018] (732) |
|
|
Hyperprolactinemia [MESH:D006966] (603) |
|
|
Growth Hormone-Secreting Pituitary Adenoma [MESH:D049912] (383) |
|
|
Prolactinoma [MESH:D015175] (312) |
|
|
|
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
Myoclonic dystonia [MESH:C536096] (245) |
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Pain [MESH:D010146] (3875) |
|
|
Seizures [MESH:D012640] (4514) |
|
|
Catalepsy [MESH:D002375] (1429) |
|
|
Hyperkinesis [MESH:D006948] (1799) |
|
|
Tremor [MESH:D014202] (840) |
|
|
Memory Disorders [MESH:D008569] (3233) |
|
|
Learning Disorders [MESH:D007859] (2727) |
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
|
|
|
Brain Injuries [MESH:D001930] (3431) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Leydig Cell Tumor [MESH:D007984] (267) |
|
|
Prostatic Hyperplasia [MESH:D011470] (336) |
|
|
Erectile Dysfunction [MESH:D007172] (1791) |
|
|
|
|
|
|
|
|
|
|
|
Leydig Cell Tumor [MESH:D007984] (267) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
|
|
Endometriosis [MESH:D004715] (2461) |
|
|
Sexual Dysfunction, Physiological [MESH:D012735] (270) |
|
|
Infertility, Female [MESH:D007247] (2184) |
|
|
Pregnancy Complications, Cardiovascular [MESH:D011249] (1994) |
|
|
Fetal Resorption [MESH:D005327] (302) |
|
|
|
|
|
Galactorrhea [MESH:D005687] (233) |
|
 |
C14. Cardiovascular Diseases |
 |
 |
|
C14. Cardiovascular Diseases |
|
|
Pregnancy Complications, Cardiovascular [MESH:D011249] (1994) |
|
|
Heart Failure [MESH:D006333] (4058) |
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
Tachycardia [MESH:D013610] (3339) |
|
|
Hypertension [MESH:D006973] (5655) |
|
|
Hypotension [MESH:D007022] (4045) |
|
|
Reperfusion Injury [MESH:D015427] (4968) |
|
|
|
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
 |
C15. Hemic and Lymphatic Diseases |
 |
 |
|
C15. Hemic and Lymphatic Diseases |
|
|
Anemia [MESH:D000740] (3966) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
Lupus Erythematosus, Systemic [MESH:D008180] (2317) |
|
|
|
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
Gynecomastia [MESH:D006177] (484) |
|
|
Galactorrhea [MESH:D005687] (233) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
 |
C19. Endocrine System Diseases |
 |
 |
|
C19. Endocrine System Diseases |
|
|
|
|
|
|
|
|
Growth Hormone-Secreting Pituitary Adenoma [MESH:D049912] (383) |
|
|
Prolactinoma [MESH:D015175] (312) |
|
|
|
|
|
Leydig Cell Tumor [MESH:D007984] (267) |
|
|
Hypogonadism [MESH:D007006] (1123) |
|
|
|
|
|
|
|
|
Leydig Cell Tumor [MESH:D007984] (267) |
|
|
Hypopituitarism [MESH:D007018] (732) |
|
|
Hyperprolactinemia [MESH:D006966] (603) |
|
|
Growth Hormone-Secreting Pituitary Adenoma [MESH:D049912] (383) |
|
|
Prolactinoma [MESH:D015175] (312) |
|
 |
C20. Immune System Diseases |
 |
 |
|
C20. Immune System Diseases |
|
|
|
|
|
Lupus Erythematosus, Systemic [MESH:D008180] (2317) |
|
 |
C22. Animal Diseases |
 |
 |
|
C22. Animal Diseases |
|
|
Mammary Neoplasms, Animal [MESH:D015674] (2735) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
Hemorrhage [MESH:D006470] (4451) |
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
Tachycardia [MESH:D013610] (3339) |
|
|
|
|
|
Fetal Resorption [MESH:D005327] (302) |
|
|
Infarction [MESH:D007238] (298) |
|
|
Amenorrhea [MESH:D000568] (817) |
|
|
Infarction [MESH:D007238] (298) |
|
|
Reperfusion Injury [MESH:D015427] (4968) |
|
|
Pain [MESH:D010146] (4511) |
|
|
Fever [MESH:D005334] (2856) |
|
|
|
|
|
Weight Gain [MESH:D015430] (2595) |
|
|
Pain [MESH:D010146] (3869) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Catalepsy [MESH:D002375] (1429) |
|
|
Hyperkinesis [MESH:D006948] (1799) |
|
|
Tremor [MESH:D014202] (840) |
|
|
Memory Disorders [MESH:D008569] (3233) |
|
|
Learning Disorders [MESH:D007859] (2727) |
|
|
Apnea [MESH:D001049] (415) |
|
 |
C25. Chemically-Induced Disorders |
 |
 |
|
C25. Chemically-Induced Disorders |
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2053) |
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
Amphetamine-Related Disorders [MESH:D019969] (2858) |
|
|
Cocaine-Related Disorders [MESH:D019970] (3054) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2052) |
|
|
Substance Withdrawal Syndrome [MESH:D013375] (2956) |
|
|
Tobacco Use Disorder [MESH:D014029] (628) |
|
|
Heroin Dependence [MESH:D006556] (950) |
|
 |
C26. Wounds and Injuries |
 |
 |
|
C26. Wounds and Injuries |
|
|
|
|
|
Brain Injuries [MESH:D001930] (3431) |
|
|
|
|
|
Brain Injuries [MESH:D001930] (3431) |
|
 |
D03. Heterocyclic Compounds |
 |
 |
|
D03. Heterocyclic Compounds |
|
|
|
|
|
|
|
|
|
|
|
Berberine [MESH:D001599] (46) |
|
|
|
|
|
Berberine [MESH:D001599] (46) |
|
 |
D27. Chemical Actions and Uses |
 |
 |
|
D27. Chemical Actions and Uses |
|
|
|
|
|
|
|
|
|
|
|
Dopamine Agonists [MESH:D018491] (20) |
|
|
Dopamine Antagonists [MESH:D018492] (12) |
|
|
|
|
|
|
|
|
Antipsychotic Agents [MESH:D014150] (18) |
|
|
|
|
|
Dopamine Agonists [MESH:D018491] (20) |
|
|
Dopamine Antagonists [MESH:D018492] (12) |
|
|
|
|
|
Calcium Channel Blockers [MESH:D002121] (34) |
|
|
|
|
|
|
|
|
Antipsychotic Agents [MESH:D014150] (18) |
|
|
|
|
|
Antipsychotic Agents [MESH:D014150] (18) |
|
 |